Directors' Shareholding

RNS Number : 5867J

Hutchison China Meditech Limited

08 April 2015

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Directors' Shareholding

London: Wednesday, 8 April 2015: Chi-Med received notifications on 8 April 2015 that the following Directors have purchased ordinary shares of US$1.00 each in Chi-Med (the "Shares") as follows:-

Director	Date of purchase	Number of Shares purchased	Purchase price	Beneficial interest in Shares following purchases
				Number of Shares	% of total issued share capital
Simon To (Executive Director and Chairman)	2 April 2015 7 April 2015	10,000 48,000	GBP13.85 GBP13.85	127,000	0.24%
Edith Shih (Non-executive Director and Company Secretary)	2 April 2015 7 April 2015	10,000 2,000	GBP13.85 GBP13.85	60,000	0.11%

Ends

Enquiries

Chi-Med    Christian Hogg, CEO	Telephone:        [phone]
Panmure Gordon (UK) Limited    Richard Gray    Andrew Potts	Telephone:        [phone]
Citigate Dewe Rogerson    Anthony Carlisle    David Dible	Telephone:       [phone] Mobile:             [phone] Mobile:             [phone]

About Chi-Med

Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products.  Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases.  Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China.  Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

Chi-Med is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13).  For more information, please visit: www.chi-med.com.

 

END

 

 

RDSSSWSWAFISEFL